EMMANUELLE CHARPENTIER
welcome
Thank you for your requests and invitations!
Due to other obligations, there may be some delay in my responses.
about
This website provides a collection of selected documentation on Emmanuelle Charpentier,
her scientific and related activities.
​
Emmanuelle is a French microbiologist, geneticist and biochemist. She received her education in Paris (France) and pursued a scientific career in academic research institutions in Paris, New York and Memphis (United States), Vienna (Austria), Umeå (Sweden) and Braunschweig (Germany). Emmanuelle is now based in Berlin (Germany).
​
Emmanuelle has devoted most of her scientific career to understanding the fundamental mechanisms of diseases, with a particular interest in infections caused by Gram-positive pathogenic bacteria such as Listeria, staphylococci and streptococci.
​
Emmanuelle is best known for her and her lab’s research on the CRISPR-Cas9 adaptive immune system in the human pathogen Streptococcus pyogenes and other bacterial species, which laid the foundation for the development of a highly versatile and specific genome editing and engineering technology. The technology known as CRISPR-Cas is revolutionizing research in the life sciences. CRISPR-Cas has opened up entirely new possibilities in biotechnology and biomedical gene therapies that have an impact on society and humanity. The field of CRISPR-Cas biology and engineering continues to grow at a rapid pace, with exciting new developments emerging almost weekly.
​
For her and her team’s contribution to the discovery of CRISPR-Cas9, Emmanuelle has received numerous honors, decorations, prizes, awards and honorary doctorates in Europe, Asia and North America. She is an elected member of national and international scientific academies.
​
Emmanuelle is the inventor and co-owner of the core intellectual property of the CRISPR-Cas9 technology. Together with Rodger Novak and Shaun Foy, she co-founded CRISPR Therapeutics and ERS Genomics to develop the CRISPR-Cas genome engineering technology for biotechnology and biomedical applications.
public relations
If you are a reporter or journalist and would like more information about Emmanuelle Charpentier, please visit the Downloads page to access CV, biography, and photographs. For more information, please email the contact below.